208 related articles for article (PubMed ID: 19815443)
1. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Nepsilon(carboxymethyl)lysine- and methylglyoxal-modified albumin with endothelial cells and macrophages. Splice variants of RAGE may limit the responsiveness of human endothelial cells to AGEs.
Lieuw-a-Fa ML; Schalkwijk CG; Engelse M; van Hinsbergh VW
Thromb Haemost; 2006 Feb; 95(2):320-8. PubMed ID: 16493495
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products.
Mangalmurti NS; Chatterjee S; Cheng G; Andersen E; Mohammed A; Siegel DL; Schmidt AM; Albelda SM; Lee JS
Transfusion; 2010 Nov; 50(11):2353-61. PubMed ID: 20492604
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
[TBL] [Abstract][Full Text] [Related]
7. Interaction of glycated human serum albumin with endothelial cells in a hemodynamic environment: structural and functional correlates.
Bala K; Gomes J; Gohil NK
Mol Biosyst; 2011 Nov; 7(11):3036-41. PubMed ID: 21866295
[TBL] [Abstract][Full Text] [Related]
8. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression.
Kislinger T; Fu C; Huber B; Qu W; Taguchi A; Du Yan S; Hofmann M; Yan SF; Pischetsrieder M; Stern D; Schmidt AM
J Biol Chem; 1999 Oct; 274(44):31740-9. PubMed ID: 10531386
[TBL] [Abstract][Full Text] [Related]
9. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
10. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
12. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.
Guo ZJ; Niu HX; Hou FF; Zhang L; Fu N; Nagai R; Lu X; Chen BH; Shan YX; Tian JW; Nagaraj RH; Xie D; Zhang X
Antioxid Redox Signal; 2008 Oct; 10(10):1699-712. PubMed ID: 18576917
[TBL] [Abstract][Full Text] [Related]
13. Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells.
Higashimoto Y; Matsui T; Nishino Y; Taira J; Inoue H; Takeuchi M; Yamagishi S
Microvasc Res; 2013 Nov; 90():64-70. PubMed ID: 24012635
[TBL] [Abstract][Full Text] [Related]
14. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
15. Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation.
Boulanger E; Grossin N; Wautier MP; Taamma R; Wautier JL
Kidney Int; 2007 Jan; 71(2):126-33. PubMed ID: 17149374
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.
Yan SD; Schmidt AM; Anderson GM; Zhang J; Brett J; Zou YS; Pinsky D; Stern D
J Biol Chem; 1994 Apr; 269(13):9889-97. PubMed ID: 8144582
[TBL] [Abstract][Full Text] [Related]
17. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
18. The Receptor for Advanced Glycation End Products (Rage) and Its Ligands in Plasma and Infrainguinal Bypass Vein.
Malmstedt J; Frebelius S; Lengquist M; Jörneskog G; Wang J; Swedenborg J
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):579-86. PubMed ID: 26905625
[TBL] [Abstract][Full Text] [Related]
19. Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration.
Xu Y; Feng L; Wang S; Zhu Q; Zheng Z; Xiang P; He B; Tang D
J Ethnopharmacol; 2011 Sep; 137(1):359-70. PubMed ID: 21669275
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
